Search - tctmd.com

Displaying 281 - 300 of 652

Sort: Relevancy | Date

SCCT 201DET02X-AMI: Oxygen Takes Another Hit as More Data Show No Pain Relief During PCI

News Daily News

DET02X-AMI: Oxygen Takes Another Hit as More Data Show No Pain Relief During PCI

August 30, 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

News Conference News ESC 2018

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

August 28, 2018

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

News Conference News ESC 2018

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

Michael O'Riordan

August 28, 2018

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

News Conference News ESC 2018

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

August 27, 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

August 27, 2018

Ten-Year Follow-up Proves Disappointing for Bilateral Arterial Grafts in ART

News Conference News ESC 2018

Ten-Year Follow-up Proves Disappointing for Bilateral Arterial Grafts in ART

August 26, 2018

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

News Conference News ESC 2018

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

August 26, 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

August 26, 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

August 26, 2018

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

News Conference News ESC 2018

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

August 26, 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

August 25, 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy

News Daily News

AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy

August 24, 2018

Physician Conflict of Interest Disclosures to Journals for Device-Industry Ties Fall Short

News Daily News

Physician Conflict of Interest Disclosures to Journals for Device-Industry Ties Fall Short

August 24, 2018

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

Sticky Business: Will Taxes on Sugary Sodas Help to Dilute America’s Cardiometabolic Crisis?

News Features

Sticky Business: Will Taxes on Sugary Sodas Help to Dilute America’s Cardiometabolic Crisis?

August 23, 2018

Diversity in Heart Failure Trials Still Falls Short

News Daily News

Diversity in Heart Failure Trials Still Falls Short

August 22, 2018

Reducing CV Risk May Improve Brain Health at Any Stage in Life, Studies Hint

News Daily News

Reducing CV Risk May Improve Brain Health at Any Stage in Life, Studies Hint

August 22, 2018

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

News Daily News

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

Michael O'Riordan

August 21, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.